StockData
Thermo Fisher Scientific Inc. logo

Thermo Fisher Scientific Inc. (TMO) operating KPIs

TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3027% above fair value
$697.00−12.18 (-1.72%)

Close on Oct 30, 2026Market cap $257.71BP/E 36.8Yield 0.25%

Thermo Fisher Scientific số phê duyệt thiết bị rủi ro cao FDA PMA & Supplements được cấp của Thermo Fisher (openFDA)

U.S. FDA openFDA Premarket Approval (PMA) API

QuarterlyAnnualMonthly
Latest, Sep 2026
1
Period ended Sep 30, 2026
Change on a year earlier
–
0 in Sep 2025
History
129 months
Since Jan 2016
Sources
1
openFDA Premarket Approvals (PMA & Supplements) — Thermo Fisher & Subsidiaries

Monthly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedSố phê duyệt thiết bị rủi ro cao FDA PMA & Supplements được cấp của Thermo Fisher (openFDA)Year on yearSource
Sep 2026Sep 30, 20261–openFDA Premarket Approvals (PMA & Supplements) — Thermo Fisher & Subsidiaries ↗
Aug 2026Aug 31, 20261-50.0%openFDA Premarket Approvals (PMA & Supplements) — Thermo Fisher & Subsidiaries ↗
Jul 2026Jul 31, 202610.0%openFDA Premarket Approvals (PMA & Supplements) — Thermo Fisher & Subsidiaries ↗
Jun 2026Jun 30, 20261–openFDA Premarket Approvals (PMA & Supplements) — Thermo Fisher & Subsidiaries ↗
May 2026May 31, 20260–openFDA Premarket Approvals (PMA & Supplements) — Thermo Fisher & Subsidiaries ↗
Apr 2026Apr 30, 20260–openFDA Premarket Approvals (PMA & Supplements) — Thermo Fisher & Subsidiaries ↗
Mar 2026Mar 31, 20261–openFDA Premarket Approvals (PMA & Supplements) — Thermo Fisher & Subsidiaries ↗
Feb 2026Feb 28, 20260–openFDA Premarket Approvals (PMA & Supplements) — Thermo Fisher & Subsidiaries ↗
Jan 2026Jan 31, 20261–openFDA Premarket Approvals (PMA & Supplements) — Thermo Fisher & Subsidiaries ↗
Dec 2025Dec 31, 20251–openFDA Premarket Approvals (PMA & Supplements) — Thermo Fisher & Subsidiaries ↗
Nov 2025Nov 30, 20252–openFDA Premarket Approvals (PMA & Supplements) — Thermo Fisher & Subsidiaries ↗
Oct 2025Oct 31, 20256+500.0%openFDA Premarket Approvals (PMA & Supplements) — Thermo Fisher & Subsidiaries ↗
Sep 2025Sep 30, 20250–openFDA Premarket Approvals (PMA & Supplements) — Thermo Fisher & Subsidiaries ↗
Aug 2025Aug 31, 20252–openFDA Premarket Approvals (PMA & Supplements) — Thermo Fisher & Subsidiaries ↗
Jul 2025Jul 31, 202510.0%openFDA Premarket Approvals (PMA & Supplements) — Thermo Fisher & Subsidiaries ↗
Jun 2025Jun 30, 20250-100.0%openFDA Premarket Approvals (PMA & Supplements) — Thermo Fisher & Subsidiaries ↗

Cite this data

StockData. (2026). Thermo Fisher Scientific Số phê duyệt thiết bị rủi ro cao FDA PMA & Supplements được cấp của Thermo Fisher (openFDA), monthly Jan 2016–Sep 2026 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/fda_pma_company

See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.